SynthesisBMC anesthesiology2025
Intraoperative hypotension prediction in cardiac and noncardiac procedures: is HPI truly worthwhile? A systematic review and meta-analysis.
Synthesis in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Predictive Paradigm in Perioperative Hemodynamic Management: The Role of Artificial Intelligence in Major Spine Surgery.Journal of clinical medicine · 2026Review
- Comparison of Hemodynamic Management by Hypotension Prediction Index or Goal-Directed Therapy in Radical Cystectomies: A Prospective Observational Study.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntraoperative hypotension (IOH), defined as a mean arterial pressure (MAP) below 65 mmHg, is a common complication during surgery and is associated with significant postoperative morbidity, including acute kidney injury, myocardial injury, stroke, and increased mortality. Despite the availability of traditional monitoring techniques, predicting and preventing IOH remains a challenge. The Hypotension Prediction Index (HPI), a machine-learning algorithm developed by Edwards Lifesciences, aims to predict IOH by analyzing real-time arterial waveform data, offering an opportunity for proactive management.
objectiveThis systematic review and meta-analysis evaluate the efficacy of the HPI in predicting and preventing IOH in cardiac and non-cardiac surgeries compared to standard blood pressure monitoring techniques.
methodsA comprehensive search was conducted in PubMed, Scopus, Embase, and Web of Science databases for studies published from January 2019 to May 2024. Studies were included if they utilized machine learning algorithms, including HPI, to predict or detect IOH in adult surgical patients. Sensitivity, specificity, area under the curve (AUC), and time-weighted average (TWA) of hypotension were the primary outcomes. Subgroup analyses were performed to evaluate differences between cardiac and non-cardiac surgeries. Meta-analytic methods were applied using random-effects models to account for study variability.
resultsA total of 22 studies were included, encompassing both cardiac and non-cardiac procedures. The HPI demonstrated an overall sensitivity of 83% and specificity of 83% in predicting IOH. The pooled AUC for all surgeries was 0.90. However, subgroup analysis revealed variability in HPI performance between cardiac and non-cardiac surgeries, with lower diagnostic odds ratios (DOR) in cardiac settings. HPI combined with invasive arterial blood pressure monitoring reduced the TWA of hypotension more effectively than either invasive or non-invasive methods alone. The comparison of HPI and MAP for diagnostic accuracy showed minimal differences across all time frames, with SMD values close to zero.
conclusionOur study shows that the HPI has high sensitivity and specificity in predicting intraoperative hypotension, but its clinical advantage over standard MAP-based monitoring is uncertain. While HPI reduces hypotension duration, this may not improve cardiovascular or renal outcomes. Further independent trials are needed to validate its effectiveness before widespread adoption, and it should be considered alongside simpler interventions like staff education and MAP targeting in the meantime.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.